Our paediatric oncology service cares for children and young people under the age of 21 who have cancer.
We provide one of the leading services in the world for childhood cancer research and the development of innovative treatments.
Our department is one of the largest, most advanced in the UK, providing a comprehensive range of leading-edge cancer services, chemotherapy, radiotherapy and specific surgery specialisms for children, through multi-disciplinary teams including doctors, nurses and therapists.
We currently have over 1000 children undergoing treatment, or receiving long term follow up care, and our team treats over 100 new children and teenagers every year.
Our 24 bed paediatric oncology unit is located in the Great North Children’s Hospital and includes a dedicated space for young people in the teenage cancer unit.
The unit receives support from other paediatric specialties in the wider children’s hospital and additional facilities within the larger Royal Victoria Infirmary site.
Specialist multi-disciplinary teams
Our highly skilled multidisciplinary teams are made up of world-leading consultants with expertise including brain, bone and soft tissue tumours, sarcomas, neuroblastomas, novel therapies and long-term follow up.
Working closely with highly trained and experienced nurses and therapists, the combined team delivers bespoke and tailored treatment and care, including an internationally renowned research service, genomics and genetic diagnostics, and paediatric pathology.
Childhood cancer research
Our clinical service and consultants are closely aligned with the childhood cancer research unit at Newcastle University.
We have 19 principal investigators and 100 clinical and non-clinical researchers based at the £5million Wolfson Childhood Cancer Research Centre.
Newcastle is the lead site for children’s cancer for the National Institute for Health and Care Research (NIHR) Children and Young Persons Medical Technology Co-operative, which looks at the development and integration of new technology in children’s medicine.
Our paediatric oncology consultants are all members of the International Society for Paediatric Oncology.
European Innovative Therapies for Children’s Cancer
The service is a national Experimental Cancer Medicine Centre and is a European Innovative Therapies for Children’s Cancer (ITCC) ‘First in Child’ trial site.
We are one of only 20 locations in Europe offering a portfolio of early phase clinical trials on a regional and national basis.